Glenn Furuta
Concepts (719)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Eosinophilic Esophagitis | 125 | 2024 | 308 | 22.800 |
Why?
| Eosinophilia | 76 | 2023 | 185 | 12.800 |
Why?
| Eosinophils | 56 | 2023 | 283 | 8.730 |
Why?
| Enteritis | 38 | 2023 | 78 | 6.840 |
Why?
| Esophagitis | 32 | 2023 | 66 | 6.480 |
Why?
| Gastritis | 37 | 2023 | 82 | 5.980 |
Why?
| Esophagus | 38 | 2022 | 237 | 5.920 |
Why?
| Gastroesophageal Reflux | 26 | 2022 | 248 | 2.990 |
Why?
| Colitis | 19 | 2019 | 219 | 2.700 |
Why?
| Proton Pump Inhibitors | 17 | 2022 | 98 | 2.550 |
Why?
| Intestinal Mucosa | 25 | 2019 | 531 | 2.520 |
Why?
| Esophagoscopy | 25 | 2023 | 190 | 2.080 |
Why?
| Gastrointestinal Diseases | 10 | 2019 | 187 | 2.020 |
Why?
| Food Hypersensitivity | 18 | 2023 | 261 | 1.880 |
Why?
| Gastrointestinal Tract | 7 | 2019 | 175 | 1.870 |
Why?
| Epithelial Cells | 17 | 2024 | 963 | 1.760 |
Why?
| Child | 114 | 2023 | 19137 | 1.740 |
Why?
| Endoscopy, Gastrointestinal | 15 | 2022 | 202 | 1.580 |
Why?
| Humans | 236 | 2024 | 119032 | 1.480 |
Why?
| Hypersensitivity | 11 | 2022 | 270 | 1.470 |
Why?
| Anti-Inflammatory Agents | 13 | 2019 | 467 | 1.430 |
Why?
| Microbiota | 5 | 2022 | 656 | 1.400 |
Why?
| Inflammatory Bowel Diseases | 7 | 2022 | 290 | 1.330 |
Why?
| Gastroenteritis | 7 | 2023 | 64 | 1.220 |
Why?
| Adolescent | 66 | 2023 | 18483 | 1.130 |
Why?
| Mucous Membrane | 8 | 2023 | 113 | 1.090 |
Why?
| Endoscopy | 6 | 2023 | 272 | 1.080 |
Why?
| Child, Preschool | 49 | 2023 | 9493 | 1.030 |
Why?
| Esophageal Mucosa | 3 | 2019 | 18 | 1.020 |
Why?
| Tight Junctions | 4 | 2024 | 69 | 1.000 |
Why?
| Esophageal Stenosis | 8 | 2022 | 47 | 0.980 |
Why?
| Mast Cells | 12 | 2022 | 115 | 0.960 |
Why?
| Diet Therapy | 5 | 2018 | 38 | 0.960 |
Why?
| Quality of Life | 12 | 2023 | 2369 | 0.940 |
Why?
| Biopsy | 22 | 2023 | 1079 | 0.940 |
Why?
| Virtual Reality | 2 | 2021 | 38 | 0.930 |
Why?
| Claudin-1 | 2 | 2019 | 17 | 0.840 |
Why?
| Adrenal Cortex Hormones | 9 | 2019 | 521 | 0.830 |
Why?
| Adult | 65 | 2023 | 31525 | 0.820 |
Why?
| Glucocorticoids | 8 | 2023 | 547 | 0.820 |
Why?
| Male | 93 | 2023 | 57818 | 0.800 |
Why?
| Allergens | 9 | 2023 | 425 | 0.800 |
Why?
| Gastroenterology | 3 | 2020 | 158 | 0.790 |
Why?
| Immunity, Mucosal | 3 | 2016 | 86 | 0.770 |
Why?
| Diagnosis, Differential | 21 | 2021 | 1384 | 0.750 |
Why?
| Deglutition Disorders | 10 | 2023 | 131 | 0.740 |
Why?
| Collagen | 4 | 2015 | 433 | 0.730 |
Why?
| Severity of Illness Index | 14 | 2022 | 2674 | 0.730 |
Why?
| Colon | 7 | 2019 | 238 | 0.730 |
Why?
| Female | 87 | 2023 | 61588 | 0.720 |
Why?
| Peanut Hypersensitivity | 7 | 2017 | 204 | 0.720 |
Why?
| Antibodies, Monoclonal | 6 | 2017 | 1285 | 0.700 |
Why?
| Dilatation | 8 | 2022 | 56 | 0.680 |
Why?
| Cytokines | 11 | 2020 | 1900 | 0.680 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2019 | 246 | 0.670 |
Why?
| Leukocyte Count | 11 | 2021 | 305 | 0.670 |
Why?
| Inflammation | 15 | 2024 | 2571 | 0.670 |
Why?
| Interleukin-5 | 3 | 2014 | 31 | 0.660 |
Why?
| Fibrosis | 4 | 2017 | 483 | 0.660 |
Why?
| GATA3 Transcription Factor | 2 | 2018 | 26 | 0.650 |
Why?
| Eosinophil Granule Proteins | 4 | 2012 | 21 | 0.650 |
Why?
| Crohn Disease | 4 | 2020 | 197 | 0.650 |
Why?
| Epithelium | 8 | 2023 | 305 | 0.650 |
Why?
| Prospective Studies | 19 | 2023 | 6477 | 0.640 |
Why?
| Diet | 7 | 2022 | 1155 | 0.640 |
Why?
| Animals | 52 | 2023 | 33399 | 0.630 |
Why?
| Tumor Necrosis Factor-alpha | 7 | 2013 | 1175 | 0.630 |
Why?
| Family | 5 | 2014 | 587 | 0.600 |
Why?
| Child Development Disorders, Pervasive | 3 | 2012 | 61 | 0.600 |
Why?
| Intestines | 7 | 2021 | 332 | 0.600 |
Why?
| Fluticasone | 7 | 2023 | 87 | 0.600 |
Why?
| Infant | 31 | 2023 | 8295 | 0.590 |
Why?
| Endoscopy, Digestive System | 6 | 2021 | 111 | 0.580 |
Why?
| Receptors, CCR3 | 2 | 2018 | 8 | 0.580 |
Why?
| Asthma | 7 | 2023 | 2159 | 0.570 |
Why?
| Claudins | 3 | 2024 | 24 | 0.560 |
Why?
| Probiotics | 1 | 2016 | 49 | 0.550 |
Why?
| Arachis | 5 | 2017 | 152 | 0.540 |
Why?
| Drug Discovery | 2 | 2017 | 124 | 0.540 |
Why?
| Enterocolitis | 2 | 2013 | 32 | 0.540 |
Why?
| Intestinal Diseases, Parasitic | 1 | 2015 | 11 | 0.540 |
Why?
| Interleukin-33 | 1 | 2015 | 39 | 0.530 |
Why?
| Ileum | 1 | 2015 | 100 | 0.520 |
Why?
| Celiac Disease | 2 | 2015 | 267 | 0.520 |
Why?
| Peptides | 6 | 2018 | 879 | 0.510 |
Why?
| Administration, Oral | 5 | 2023 | 756 | 0.510 |
Why?
| Gastrointestinal Agents | 3 | 2019 | 58 | 0.510 |
Why?
| Constipation | 2 | 2012 | 76 | 0.500 |
Why?
| Interleukin-13 | 4 | 2021 | 135 | 0.490 |
Why?
| Hypereosinophilic Syndrome | 1 | 2014 | 9 | 0.490 |
Why?
| Ileitis | 2 | 2011 | 25 | 0.490 |
Why?
| Antibodies, Monoclonal, Humanized | 4 | 2023 | 667 | 0.490 |
Why?
| Bottle Feeding | 1 | 2014 | 22 | 0.490 |
Why?
| Signal Transduction | 9 | 2020 | 4713 | 0.490 |
Why?
| Retrospective Studies | 27 | 2023 | 12990 | 0.480 |
Why?
| Steroids | 5 | 2023 | 153 | 0.470 |
Why?
| Receptors, Calcium-Sensing | 2 | 2012 | 6 | 0.470 |
Why?
| Disease Models, Animal | 11 | 2017 | 3730 | 0.460 |
Why?
| Algorithms | 7 | 2022 | 1543 | 0.450 |
Why?
| Patient Reported Outcome Measures | 3 | 2021 | 252 | 0.450 |
Why?
| beta-Defensins | 1 | 2013 | 22 | 0.450 |
Why?
| Mother-Child Relations | 1 | 2014 | 109 | 0.450 |
Why?
| Monitoring, Physiologic | 2 | 2014 | 272 | 0.440 |
Why?
| Immunotherapy | 3 | 2020 | 493 | 0.440 |
Why?
| Mice, Transgenic | 3 | 2019 | 2025 | 0.430 |
Why?
| Mucositis | 1 | 2012 | 20 | 0.430 |
Why?
| Young Adult | 21 | 2022 | 10799 | 0.430 |
Why?
| Mice | 29 | 2019 | 15528 | 0.420 |
Why?
| Consensus | 8 | 2022 | 534 | 0.410 |
Why?
| Feeding Behavior | 5 | 2019 | 601 | 0.410 |
Why?
| Esophageal Diseases | 2 | 2008 | 26 | 0.410 |
Why?
| Rare Diseases | 1 | 2012 | 113 | 0.410 |
Why?
| Neutrophils | 8 | 2017 | 1233 | 0.400 |
Why?
| Hypoxia-Inducible Factor 1 | 6 | 2020 | 64 | 0.390 |
Why?
| Eosinophil Peroxidase | 3 | 2018 | 7 | 0.390 |
Why?
| Adrenal Insufficiency | 2 | 2022 | 30 | 0.390 |
Why?
| Breast Feeding | 1 | 2014 | 386 | 0.380 |
Why?
| Cell Communication | 3 | 2017 | 281 | 0.370 |
Why?
| National Institute of Allergy and Infectious Diseases (U.S.) | 9 | 2017 | 28 | 0.370 |
Why?
| Dermatitis, Atopic | 1 | 2014 | 332 | 0.370 |
Why?
| Food | 3 | 2020 | 163 | 0.360 |
Why?
| Ribonucleases | 2 | 2000 | 53 | 0.360 |
Why?
| Androstadienes | 3 | 2014 | 95 | 0.350 |
Why?
| Interleukin-8 | 2 | 2000 | 249 | 0.350 |
Why?
| Cell Degranulation | 5 | 2020 | 38 | 0.350 |
Why?
| Blood Proteins | 3 | 2002 | 248 | 0.350 |
Why?
| MicroRNAs | 3 | 2024 | 637 | 0.340 |
Why?
| Dexamethasone | 7 | 2012 | 320 | 0.340 |
Why?
| Biological Products | 2 | 2023 | 170 | 0.330 |
Why?
| Diagnostic Techniques, Digestive System | 3 | 2018 | 10 | 0.330 |
Why?
| Biomarkers | 8 | 2022 | 3590 | 0.320 |
Why?
| United States | 26 | 2023 | 12557 | 0.320 |
Why?
| Treatment Outcome | 16 | 2023 | 9346 | 0.320 |
Why?
| Budesonide | 3 | 2022 | 85 | 0.320 |
Why?
| Age Factors | 9 | 2020 | 2995 | 0.320 |
Why?
| Patient Compliance | 1 | 2012 | 537 | 0.310 |
Why?
| Immunoglobulin E | 8 | 2017 | 366 | 0.310 |
Why?
| Practice Guidelines as Topic | 5 | 2020 | 1440 | 0.310 |
Why?
| Nuclear Proteins | 4 | 2018 | 597 | 0.310 |
Why?
| Fibroblasts | 3 | 2021 | 843 | 0.310 |
Why?
| Pregnenediones | 2 | 2021 | 21 | 0.310 |
Why?
| History, 20th Century | 3 | 2014 | 281 | 0.310 |
Why?
| Eosinophil Major Basic Protein | 2 | 2008 | 6 | 0.300 |
Why?
| Deglutition | 2 | 2019 | 65 | 0.300 |
Why?
| Gene Expression Regulation | 8 | 2021 | 2446 | 0.290 |
Why?
| Case-Control Studies | 8 | 2022 | 3173 | 0.290 |
Why?
| Chemokine CCL24 | 2 | 2019 | 9 | 0.280 |
Why?
| Th2 Cells | 3 | 2018 | 164 | 0.280 |
Why?
| Middle Aged | 23 | 2021 | 27627 | 0.270 |
Why?
| Barrett Esophagus | 1 | 2008 | 154 | 0.270 |
Why?
| Biomedical Research | 4 | 2019 | 612 | 0.270 |
Why?
| Evidence-Based Medicine | 3 | 2020 | 693 | 0.270 |
Why?
| Surveys and Questionnaires | 8 | 2022 | 4709 | 0.260 |
Why?
| Milk Hypersensitivity | 2 | 2003 | 19 | 0.260 |
Why?
| Esophagitis, Peptic | 2 | 2006 | 18 | 0.260 |
Why?
| Biological Assay | 1 | 2006 | 122 | 0.260 |
Why?
| Anti-Allergic Agents | 3 | 2015 | 41 | 0.250 |
Why?
| Caco-2 Cells | 5 | 2012 | 66 | 0.250 |
Why?
| Endosonography | 2 | 2003 | 142 | 0.250 |
Why?
| Mice, Inbred C57BL | 11 | 2017 | 4914 | 0.240 |
Why?
| Neuropeptides | 2 | 2001 | 68 | 0.240 |
Why?
| Cell Movement | 5 | 2018 | 897 | 0.240 |
Why?
| Baclofen | 1 | 2003 | 12 | 0.240 |
Why?
| Massage | 2 | 2014 | 44 | 0.230 |
Why?
| History, 21st Century | 2 | 2014 | 170 | 0.230 |
Why?
| Practice Patterns, Physicians' | 3 | 2017 | 1200 | 0.230 |
Why?
| Dermatologic Agents | 1 | 2023 | 57 | 0.220 |
Why?
| Milk Proteins | 1 | 2003 | 37 | 0.220 |
Why?
| Colitis, Microscopic | 1 | 2022 | 3 | 0.210 |
Why?
| Homeostasis | 3 | 2021 | 594 | 0.210 |
Why?
| Extracellular Matrix | 1 | 2006 | 446 | 0.210 |
Why?
| Cell Line, Transformed | 2 | 2019 | 136 | 0.210 |
Why?
| Tetraspanins | 1 | 2021 | 16 | 0.210 |
Why?
| Hypoxia | 3 | 2024 | 963 | 0.210 |
Why?
| Phenotype | 7 | 2022 | 3004 | 0.200 |
Why?
| Administration, Topical | 3 | 2020 | 141 | 0.200 |
Why?
| Infant, Newborn | 5 | 2023 | 5256 | 0.200 |
Why?
| Combined Modality Therapy | 2 | 2019 | 1167 | 0.200 |
Why?
| Sex Chromosomes | 1 | 2021 | 48 | 0.200 |
Why?
| Oxazolone | 2 | 2012 | 5 | 0.200 |
Why?
| RNA, Ribosomal, 16S | 2 | 2015 | 514 | 0.200 |
Why?
| Aneuploidy | 1 | 2021 | 88 | 0.200 |
Why?
| Growth Substances | 1 | 2001 | 136 | 0.200 |
Why?
| Esophageal Sphincter, Lower | 1 | 2020 | 10 | 0.200 |
Why?
| Neutrophil Activation | 2 | 2003 | 100 | 0.190 |
Why?
| Mucins | 1 | 2001 | 59 | 0.190 |
Why?
| Transition to Adult Care | 1 | 2021 | 58 | 0.190 |
Why?
| Intestine, Small | 2 | 2019 | 131 | 0.190 |
Why?
| Polysaccharide-Lyases | 1 | 2000 | 13 | 0.190 |
Why?
| Telemedicine | 2 | 2019 | 668 | 0.190 |
Why?
| Heparan Sulfate Proteoglycans | 1 | 2000 | 21 | 0.190 |
Why?
| Esophageal Achalasia | 1 | 2020 | 25 | 0.190 |
Why?
| Genetic Loci | 2 | 2021 | 281 | 0.190 |
Why?
| Gene Expression | 6 | 2021 | 1492 | 0.190 |
Why?
| Chemokines | 2 | 2015 | 230 | 0.190 |
Why?
| Peroxidase | 2 | 2015 | 170 | 0.190 |
Why?
| RNA, Messenger | 6 | 2018 | 2661 | 0.180 |
Why?
| Chemokines, CC | 1 | 2000 | 30 | 0.180 |
Why?
| Esophageal Motility Disorders | 2 | 2011 | 24 | 0.180 |
Why?
| Dietary Exposure | 1 | 2019 | 7 | 0.180 |
Why?
| DNA-Binding Proteins | 3 | 2018 | 1346 | 0.180 |
Why?
| Chemokine CCL26 | 1 | 2019 | 7 | 0.180 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 1 | 2022 | 246 | 0.180 |
Why?
| Skin Tests | 6 | 2017 | 135 | 0.180 |
Why?
| Nanoparticles | 3 | 2018 | 325 | 0.180 |
Why?
| Genetic Association Studies | 1 | 2021 | 371 | 0.180 |
Why?
| Feeding and Eating Disorders | 2 | 2018 | 125 | 0.170 |
Why?
| Gastrostomy | 2 | 2018 | 93 | 0.170 |
Why?
| Genetic Predisposition to Disease | 4 | 2021 | 2275 | 0.170 |
Why?
| Muscle Proteins | 1 | 2001 | 219 | 0.170 |
Why?
| Models, Biological | 2 | 2008 | 1715 | 0.170 |
Why?
| Immunity, Innate | 2 | 2020 | 745 | 0.170 |
Why?
| Anxiety | 2 | 2017 | 846 | 0.170 |
Why?
| Penicillamine | 1 | 1998 | 24 | 0.170 |
Why?
| Nutritional Status | 3 | 2018 | 300 | 0.170 |
Why?
| Nutrition Therapy | 1 | 2019 | 32 | 0.170 |
Why?
| Enteral Nutrition | 1 | 2020 | 172 | 0.170 |
Why?
| Hepatolenticular Degeneration | 1 | 1998 | 18 | 0.170 |
Why?
| Integrins | 1 | 2019 | 82 | 0.170 |
Why?
| Feasibility Studies | 2 | 2019 | 749 | 0.170 |
Why?
| Anaphylaxis | 3 | 2011 | 146 | 0.170 |
Why?
| Protein Stability | 1 | 2019 | 164 | 0.170 |
Why?
| Self Report | 3 | 2018 | 699 | 0.170 |
Why?
| Stem Cell Factor | 1 | 1998 | 14 | 0.170 |
Why?
| Abscess | 2 | 2012 | 75 | 0.170 |
Why?
| Nephrotic Syndrome | 1 | 1998 | 33 | 0.170 |
Why?
| Chelating Agents | 1 | 1998 | 74 | 0.170 |
Why?
| Arachidonic Acids | 1 | 1998 | 57 | 0.160 |
Why?
| Time Factors | 5 | 2019 | 6414 | 0.160 |
Why?
| Chromosomes, Human, Pair 16 | 1 | 2018 | 30 | 0.160 |
Why?
| Cell Hypoxia | 5 | 2004 | 220 | 0.160 |
Why?
| Colonic Diseases | 1 | 2018 | 26 | 0.160 |
Why?
| Population Groups | 1 | 2018 | 58 | 0.160 |
Why?
| Mice, Inbred Strains | 4 | 2011 | 405 | 0.160 |
Why?
| Radiography | 4 | 2015 | 861 | 0.160 |
Why?
| Clinical Trials as Topic | 3 | 2019 | 968 | 0.160 |
Why?
| Hypersensitivity, Immediate | 1 | 2018 | 59 | 0.160 |
Why?
| Placebos | 1 | 2018 | 202 | 0.160 |
Why?
| Respiratory Hypersensitivity | 1 | 2018 | 65 | 0.160 |
Why?
| Histological Techniques | 1 | 2018 | 43 | 0.160 |
Why?
| Prevalence | 5 | 2021 | 2326 | 0.160 |
Why?
| Aged | 12 | 2021 | 19661 | 0.150 |
Why?
| Eczema | 2 | 2017 | 85 | 0.150 |
Why?
| Internet | 1 | 2022 | 633 | 0.150 |
Why?
| Chemokine CCL11 | 2 | 2011 | 22 | 0.150 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2003 | 532 | 0.150 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2019 | 1244 | 0.150 |
Why?
| Cell Line | 7 | 2018 | 2707 | 0.150 |
Why?
| Anesthetics, Intravenous | 1 | 2017 | 34 | 0.150 |
Why?
| Transcription Factors | 2 | 2004 | 1570 | 0.150 |
Why?
| Medical History Taking | 2 | 2015 | 120 | 0.150 |
Why?
| Interdisciplinary Research | 1 | 2017 | 27 | 0.150 |
Why?
| Permeability | 3 | 2011 | 156 | 0.150 |
Why?
| Propofol | 1 | 2017 | 49 | 0.140 |
Why?
| Hydrogen-Ion Concentration | 4 | 2008 | 536 | 0.140 |
Why?
| Receptor, Adenosine A2B | 2 | 2015 | 32 | 0.140 |
Why?
| Quality Indicators, Health Care | 1 | 2019 | 295 | 0.140 |
Why?
| Dietetics | 2 | 2017 | 22 | 0.140 |
Why?
| Cells, Cultured | 8 | 2017 | 4081 | 0.140 |
Why?
| Transforming Growth Factor beta1 | 1 | 2017 | 164 | 0.140 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 143 | 0.140 |
Why?
| Serotonin | 1 | 1998 | 309 | 0.140 |
Why?
| Reproducibility of Results | 7 | 2022 | 2874 | 0.140 |
Why?
| Secale | 1 | 2015 | 1 | 0.140 |
Why?
| Hordeum | 1 | 2015 | 2 | 0.140 |
Why?
| Child Nutritional Physiological Phenomena | 1 | 2017 | 98 | 0.140 |
Why?
| Expert Testimony | 2 | 2020 | 56 | 0.140 |
Why?
| Meals | 1 | 2017 | 101 | 0.140 |
Why?
| Gastroenterologists | 1 | 2016 | 17 | 0.140 |
Why?
| Triticum | 1 | 2015 | 11 | 0.140 |
Why?
| Ubiquitin-Activating Enzymes | 1 | 2016 | 16 | 0.140 |
Why?
| Endothelial Cells | 1 | 2021 | 732 | 0.140 |
Why?
| Myeloid Cells | 1 | 2017 | 128 | 0.140 |
Why?
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2017 | 150 | 0.140 |
Why?
| Bacterial Physiological Phenomena | 1 | 2016 | 57 | 0.140 |
Why?
| Environmental Exposure | 1 | 2019 | 405 | 0.140 |
Why?
| Inflammasomes | 1 | 2017 | 120 | 0.140 |
Why?
| Glutens | 1 | 2015 | 56 | 0.130 |
Why?
| Helminths | 1 | 2015 | 8 | 0.130 |
Why?
| Helminthiasis | 1 | 2015 | 14 | 0.130 |
Why?
| Remission Induction | 4 | 2020 | 247 | 0.130 |
Why?
| Natural Orifice Endoscopic Surgery | 1 | 2015 | 28 | 0.130 |
Why?
| Respiratory System | 1 | 2016 | 141 | 0.130 |
Why?
| Vascular Remodeling | 1 | 2017 | 152 | 0.130 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 982 | 0.130 |
Why?
| Lung | 2 | 2018 | 3666 | 0.130 |
Why?
| Patient Preference | 2 | 2022 | 170 | 0.130 |
Why?
| Fibronectins | 1 | 2015 | 114 | 0.130 |
Why?
| STAT6 Transcription Factor | 1 | 2014 | 22 | 0.130 |
Why?
| Primary Prevention | 1 | 2017 | 185 | 0.130 |
Why?
| Desmosomes | 1 | 2014 | 19 | 0.130 |
Why?
| Constriction, Pathologic | 1 | 2015 | 204 | 0.130 |
Why?
| Polymorphism, Genetic | 1 | 2018 | 642 | 0.130 |
Why?
| Mice, Knockout | 5 | 2017 | 2680 | 0.130 |
Why?
| Genetic Markers | 1 | 2016 | 348 | 0.130 |
Why?
| Calpain | 1 | 2014 | 54 | 0.130 |
Why?
| Cost of Illness | 2 | 2014 | 258 | 0.130 |
Why?
| Receptors, Interleukin-5 | 1 | 2014 | 5 | 0.120 |
Why?
| Cell Adhesion Molecules | 1 | 2015 | 180 | 0.120 |
Why?
| HT29 Cells | 2 | 2012 | 37 | 0.120 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2016 | 200 | 0.120 |
Why?
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 59 | 0.120 |
Why?
| History, 19th Century | 1 | 2014 | 61 | 0.120 |
Why?
| Prognosis | 3 | 2018 | 3443 | 0.120 |
Why?
| Rhinitis, Allergic | 1 | 2014 | 37 | 0.120 |
Why?
| Gene Expression Profiling | 3 | 2018 | 1597 | 0.120 |
Why?
| RNA, Bacterial | 1 | 2015 | 175 | 0.120 |
Why?
| Allergy and Immunology | 3 | 2020 | 57 | 0.120 |
Why?
| Medication Adherence | 1 | 2019 | 556 | 0.120 |
Why?
| Ambulatory Care | 1 | 2018 | 482 | 0.120 |
Why?
| Acute Lung Injury | 1 | 2017 | 310 | 0.120 |
Why?
| Ileal Neoplasms | 1 | 1993 | 4 | 0.120 |
Why?
| Ileocecal Valve | 1 | 1993 | 3 | 0.120 |
Why?
| Symptom Assessment | 1 | 2015 | 123 | 0.120 |
Why?
| Parents | 2 | 2020 | 1212 | 0.120 |
Why?
| Twins, Dizygotic | 1 | 2014 | 182 | 0.120 |
Why?
| Intussusception | 1 | 1993 | 27 | 0.120 |
Why?
| Leiomyosarcoma | 1 | 1993 | 23 | 0.120 |
Why?
| Predictive Value of Tests | 4 | 2022 | 1868 | 0.120 |
Why?
| Sensitivity and Specificity | 3 | 2013 | 1795 | 0.120 |
Why?
| Drug Resistance | 1 | 2014 | 167 | 0.120 |
Why?
| Immunoglobulin G | 3 | 2018 | 788 | 0.120 |
Why?
| Twins, Monozygotic | 1 | 2014 | 214 | 0.110 |
Why?
| Eosinophil Cationic Protein | 2 | 2012 | 9 | 0.110 |
Why?
| Polypharmacy | 1 | 2014 | 75 | 0.110 |
Why?
| Electric Impedance | 3 | 2017 | 101 | 0.110 |
Why?
| Viral Regulatory and Accessory Proteins | 1 | 2012 | 28 | 0.110 |
Why?
| Calcium | 3 | 2012 | 1171 | 0.110 |
Why?
| Gastrointestinal Microbiome | 2 | 2017 | 548 | 0.110 |
Why?
| Cystic Fibrosis | 2 | 2021 | 965 | 0.110 |
Why?
| Dose-Response Relationship, Drug | 2 | 2018 | 1947 | 0.110 |
Why?
| Gene-Environment Interaction | 1 | 2014 | 201 | 0.110 |
Why?
| Expressed Sequence Tags | 1 | 2012 | 38 | 0.110 |
Why?
| Host-Pathogen Interactions | 2 | 2020 | 300 | 0.110 |
Why?
| Longitudinal Studies | 1 | 2019 | 2513 | 0.110 |
Why?
| Interferon-gamma | 1 | 2016 | 737 | 0.110 |
Why?
| Lysophospholipase | 1 | 2012 | 13 | 0.110 |
Why?
| Immune Tolerance | 2 | 2017 | 334 | 0.110 |
Why?
| Gastric Mucosa | 2 | 2011 | 45 | 0.110 |
Why?
| Health Status Indicators | 1 | 2013 | 154 | 0.110 |
Why?
| Adaptation, Psychological | 2 | 2014 | 557 | 0.110 |
Why?
| Cell Cycle Proteins | 1 | 2016 | 565 | 0.110 |
Why?
| Inflammation Mediators | 1 | 2015 | 502 | 0.110 |
Why?
| Esophagogastric Junction | 2 | 2020 | 41 | 0.110 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 155 | 0.110 |
Why?
| Autophagy | 1 | 2016 | 315 | 0.110 |
Why?
| Food, Formulated | 2 | 2023 | 19 | 0.110 |
Why?
| Schools | 2 | 2013 | 411 | 0.110 |
Why?
| Genes, Bacterial | 1 | 2012 | 162 | 0.110 |
Why?
| Herpesvirus 4, Human | 1 | 2012 | 126 | 0.100 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 173 | 0.100 |
Why?
| Diet Surveys | 1 | 2012 | 85 | 0.100 |
Why?
| Genome, Bacterial | 1 | 2012 | 109 | 0.100 |
Why?
| Eating | 1 | 2014 | 369 | 0.100 |
Why?
| Endpoint Determination | 2 | 2013 | 69 | 0.100 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 333 | 0.100 |
Why?
| Metagenome | 1 | 2012 | 121 | 0.100 |
Why?
| Repressor Proteins | 1 | 2014 | 377 | 0.100 |
Why?
| Quality Improvement | 1 | 2019 | 963 | 0.100 |
Why?
| Child Behavior | 1 | 2013 | 212 | 0.100 |
Why?
| Neoplasm Proteins | 1 | 2014 | 401 | 0.100 |
Why?
| Neutrophil Infiltration | 1 | 2011 | 97 | 0.100 |
Why?
| Nerve Growth Factors | 1 | 2011 | 74 | 0.100 |
Why?
| Cyclosporine | 3 | 1997 | 173 | 0.100 |
Why?
| Specimen Handling | 1 | 2012 | 165 | 0.100 |
Why?
| Switzerland | 3 | 2015 | 27 | 0.100 |
Why?
| Patient Satisfaction | 1 | 2015 | 610 | 0.100 |
Why?
| Up-Regulation | 2 | 2012 | 872 | 0.100 |
Why?
| Th1-Th2 Balance | 1 | 2010 | 11 | 0.100 |
Why?
| Phosphorylation | 3 | 2012 | 1634 | 0.100 |
Why?
| Antigens, CD1 | 2 | 2002 | 60 | 0.100 |
Why?
| Caregivers | 1 | 2017 | 709 | 0.100 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 827 | 0.100 |
Why?
| Feeding and Eating Disorders of Childhood | 1 | 2010 | 6 | 0.100 |
Why?
| Enzyme Activation | 1 | 2012 | 828 | 0.100 |
Why?
| Equipment Design | 1 | 2012 | 519 | 0.090 |
Why?
| Professional Role | 1 | 2012 | 153 | 0.090 |
Why?
| Glycoproteins | 1 | 2012 | 319 | 0.090 |
Why?
| Transfection | 1 | 2012 | 890 | 0.090 |
Why?
| HEK293 Cells | 1 | 2012 | 625 | 0.090 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2012 | 176 | 0.090 |
Why?
| RNA, Small Interfering | 3 | 2021 | 564 | 0.090 |
Why?
| Zollinger-Ellison Syndrome | 1 | 1989 | 2 | 0.090 |
Why?
| Risk Factors | 6 | 2022 | 9003 | 0.090 |
Why?
| Transforming Growth Factor beta | 2 | 2012 | 462 | 0.090 |
Why?
| Sleep Wake Disorders | 1 | 2013 | 241 | 0.090 |
Why?
| Esophageal pH Monitoring | 1 | 2009 | 23 | 0.090 |
Why?
| Foreign Bodies | 1 | 2011 | 98 | 0.090 |
Why?
| Models, Genetic | 1 | 2012 | 595 | 0.090 |
Why?
| Sequence Analysis, DNA | 1 | 2012 | 755 | 0.090 |
Why?
| Manometry | 1 | 2009 | 89 | 0.090 |
Why?
| Stress, Psychological | 1 | 2017 | 976 | 0.090 |
Why?
| Th1 Cells | 1 | 2010 | 133 | 0.090 |
Why?
| Pilot Projects | 1 | 2014 | 1420 | 0.090 |
Why?
| Health Status | 1 | 2014 | 726 | 0.090 |
Why?
| Follow-Up Studies | 5 | 2019 | 4596 | 0.090 |
Why?
| Cohort Studies | 4 | 2020 | 5117 | 0.090 |
Why?
| Tumor Suppressor Proteins | 1 | 2011 | 289 | 0.090 |
Why?
| Fibroblast Growth Factor 9 | 1 | 2008 | 2 | 0.090 |
Why?
| Integrin beta1 | 1 | 2008 | 20 | 0.080 |
Why?
| Chemotactic Factors, Eosinophil | 2 | 2017 | 6 | 0.080 |
Why?
| Gastrectomy | 1 | 1989 | 82 | 0.080 |
Why?
| Abdominal Pain | 1 | 2010 | 134 | 0.080 |
Why?
| Advisory Committees | 2 | 2020 | 212 | 0.080 |
Why?
| Diarrhea | 1 | 2010 | 181 | 0.080 |
Why?
| 5'-Nucleotidase | 1 | 2008 | 34 | 0.080 |
Why?
| Gastric Acidity Determination | 1 | 2008 | 7 | 0.080 |
Why?
| Gastric Acid | 1 | 2008 | 15 | 0.080 |
Why?
| Cytotoxicity, Immunologic | 1 | 2009 | 204 | 0.080 |
Why?
| Chronic Disease | 2 | 2011 | 1637 | 0.080 |
Why?
| Procollagen-Proline Dioxygenase | 1 | 2008 | 20 | 0.080 |
Why?
| Social Support | 1 | 2012 | 542 | 0.080 |
Why?
| Adjuvants, Immunologic | 1 | 2009 | 207 | 0.080 |
Why?
| Paneth Cells | 1 | 2008 | 18 | 0.080 |
Why?
| Chemotaxis, Leukocyte | 2 | 2006 | 133 | 0.080 |
Why?
| Immunohistochemistry | 3 | 2012 | 1691 | 0.080 |
Why?
| Lymphoid Tissue | 1 | 2008 | 65 | 0.080 |
Why?
| Stomach | 2 | 2019 | 103 | 0.080 |
Why?
| Eosinophil-Derived Neurotoxin | 2 | 2012 | 3 | 0.080 |
Why?
| Forecasting | 2 | 2019 | 354 | 0.080 |
Why?
| Patient Education as Topic | 1 | 2012 | 699 | 0.070 |
Why?
| Dextran Sulfate | 2 | 2017 | 71 | 0.070 |
Why?
| Precision Medicine | 1 | 2010 | 363 | 0.070 |
Why?
| Immunoglobulin A | 1 | 2008 | 174 | 0.070 |
Why?
| Disease Susceptibility | 2 | 2020 | 331 | 0.070 |
Why?
| Nutritional Support | 1 | 2006 | 28 | 0.070 |
Why?
| Antibody Formation | 1 | 2008 | 276 | 0.070 |
Why?
| Wound Healing | 1 | 2008 | 270 | 0.070 |
Why?
| Flow Cytometry | 3 | 2016 | 1085 | 0.070 |
Why?
| Incidence | 2 | 2019 | 2424 | 0.070 |
Why?
| Terminology as Topic | 1 | 2007 | 211 | 0.070 |
Why?
| Cross-Sectional Studies | 3 | 2022 | 4552 | 0.070 |
Why?
| Health Services Accessibility | 1 | 2012 | 781 | 0.070 |
Why?
| Gels | 1 | 2006 | 72 | 0.070 |
Why?
| Monocytes | 2 | 2020 | 513 | 0.070 |
Why?
| Exudates and Transudates | 1 | 2005 | 14 | 0.070 |
Why?
| Blood Platelets | 1 | 2008 | 369 | 0.070 |
Why?
| Hydrocortisone | 2 | 2020 | 273 | 0.070 |
Why?
| Disease Management | 2 | 2020 | 571 | 0.060 |
Why?
| Depression | 1 | 2013 | 1137 | 0.060 |
Why?
| Child Nutrition Disorders | 2 | 2018 | 16 | 0.060 |
Why?
| Disease Progression | 2 | 2012 | 2490 | 0.060 |
Why?
| Genetic Testing | 2 | 2021 | 389 | 0.060 |
Why?
| Leukemic Infiltration | 1 | 2003 | 5 | 0.060 |
Why?
| Sigmoidoscopy | 1 | 2003 | 10 | 0.060 |
Why?
| Daunorubicin | 1 | 2003 | 23 | 0.060 |
Why?
| Enzyme Inhibitors | 1 | 2008 | 829 | 0.060 |
Why?
| Membrane Proteins | 2 | 2018 | 1056 | 0.060 |
Why?
| Thioguanine | 1 | 2003 | 20 | 0.060 |
Why?
| Adenine Nucleotides | 1 | 2003 | 20 | 0.060 |
Why?
| Receptors, Purinergic P1 | 1 | 2003 | 25 | 0.060 |
Why?
| Leukocyte Common Antigens | 1 | 2003 | 76 | 0.060 |
Why?
| Health Surveys | 2 | 2017 | 454 | 0.060 |
Why?
| Cytarabine | 1 | 2003 | 53 | 0.060 |
Why?
| Pyrophosphatases | 1 | 2003 | 22 | 0.060 |
Why?
| Cell Cycle | 1 | 2006 | 550 | 0.060 |
Why?
| Physicians | 1 | 2012 | 794 | 0.060 |
Why?
| Etoposide | 1 | 2003 | 149 | 0.060 |
Why?
| Tomography, X-Ray Computed | 1 | 2013 | 2436 | 0.060 |
Why?
| Digestive System | 1 | 2003 | 30 | 0.060 |
Why?
| Gastrointestinal Hemorrhage | 1 | 2003 | 109 | 0.060 |
Why?
| Pain | 2 | 2022 | 736 | 0.050 |
Why?
| Patient Outcome Assessment | 1 | 2023 | 122 | 0.050 |
Why?
| Recombinant Proteins | 2 | 2008 | 1308 | 0.050 |
Why?
| Adenosine | 1 | 2003 | 211 | 0.050 |
Why?
| Genome-Wide Association Study | 2 | 2021 | 1323 | 0.050 |
Why?
| Trefoil Factor-2 | 1 | 2001 | 3 | 0.050 |
Why?
| Trefoil Factor-3 | 1 | 2001 | 5 | 0.050 |
Why?
| Peptidyl-Dipeptidase A | 1 | 2021 | 56 | 0.050 |
Why?
| Myenteric Plexus | 1 | 2020 | 4 | 0.050 |
Why?
| Lymphocytes | 1 | 2003 | 347 | 0.050 |
Why?
| Rural Health | 1 | 2021 | 72 | 0.050 |
Why?
| Cell Culture Techniques | 2 | 2017 | 356 | 0.050 |
Why?
| United States Food and Drug Administration | 1 | 2021 | 175 | 0.050 |
Why?
| Klinefelter Syndrome | 1 | 2021 | 53 | 0.050 |
Why?
| Gene Silencing | 1 | 2021 | 177 | 0.050 |
Why?
| Base Sequence | 3 | 2017 | 2160 | 0.050 |
Why?
| Ubiquitins | 1 | 2000 | 34 | 0.050 |
Why?
| CD18 Antigens | 1 | 2000 | 35 | 0.050 |
Why?
| Weight Gain | 2 | 2014 | 493 | 0.050 |
Why?
| Multienzyme Complexes | 1 | 2000 | 64 | 0.050 |
Why?
| International Cooperation | 1 | 2021 | 177 | 0.050 |
Why?
| Cysteine Endopeptidases | 1 | 2000 | 61 | 0.050 |
Why?
| Acute Disease | 2 | 2015 | 941 | 0.050 |
Why?
| Sex Factors | 2 | 2017 | 1781 | 0.050 |
Why?
| HeLa Cells | 3 | 2008 | 583 | 0.050 |
Why?
| Bone Marrow Cells | 2 | 1998 | 273 | 0.050 |
Why?
| Dogs | 1 | 2001 | 371 | 0.050 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2005 | 702 | 0.050 |
Why?
| Dehydroepiandrosterone Sulfate | 1 | 2020 | 44 | 0.050 |
Why?
| Coculture Techniques | 1 | 2000 | 208 | 0.050 |
Why?
| Erythema | 1 | 2019 | 24 | 0.050 |
Why?
| Muscle, Smooth | 1 | 2000 | 157 | 0.050 |
Why?
| Ulcer | 1 | 2019 | 28 | 0.040 |
Why?
| Patient Transfer | 1 | 2021 | 143 | 0.040 |
Why?
| Autocrine Communication | 1 | 1999 | 42 | 0.040 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2000 | 144 | 0.040 |
Why?
| Amino Acids | 1 | 2023 | 465 | 0.040 |
Why?
| Dysbiosis | 1 | 2021 | 147 | 0.040 |
Why?
| Animals, Newborn | 1 | 2002 | 806 | 0.040 |
Why?
| National Institutes of Health (U.S.) | 1 | 2019 | 115 | 0.040 |
Why?
| Adrenocorticotropic Hormone | 1 | 2020 | 152 | 0.040 |
Why?
| Trientine | 1 | 1998 | 1 | 0.040 |
Why?
| Immunomodulation | 1 | 2020 | 89 | 0.040 |
Why?
| Cluster Analysis | 1 | 2020 | 481 | 0.040 |
Why?
| Cromolyn Sodium | 1 | 1998 | 13 | 0.040 |
Why?
| Retreatment | 1 | 1998 | 71 | 0.040 |
Why?
| Interdisciplinary Communication | 1 | 2020 | 191 | 0.040 |
Why?
| Organizations | 1 | 2018 | 19 | 0.040 |
Why?
| Ionophores | 1 | 1998 | 25 | 0.040 |
Why?
| Concanavalin A | 1 | 1998 | 74 | 0.040 |
Why?
| Diffusion of Innovation | 1 | 2019 | 98 | 0.040 |
Why?
| Double-Blind Method | 2 | 2014 | 1687 | 0.040 |
Why?
| Edema | 1 | 1999 | 124 | 0.040 |
Why?
| Nutrition Assessment | 2 | 2010 | 78 | 0.040 |
Why?
| Histamine | 1 | 1998 | 65 | 0.040 |
Why?
| Monosaccharide Transport Proteins | 1 | 2018 | 46 | 0.040 |
Why?
| Intersectoral Collaboration | 1 | 2018 | 60 | 0.040 |
Why?
| Lectins, C-Type | 1 | 2018 | 63 | 0.040 |
Why?
| Models, Animal | 2 | 2016 | 363 | 0.040 |
Why?
| Endopeptidases | 1 | 1998 | 73 | 0.040 |
Why?
| Culture Media, Conditioned | 1 | 1998 | 112 | 0.040 |
Why?
| International Classification of Diseases | 1 | 2019 | 122 | 0.040 |
Why?
| Delayed-Action Preparations | 1 | 2019 | 161 | 0.040 |
Why?
| Lipids | 1 | 2002 | 608 | 0.040 |
Why?
| Visual Analog Scale | 1 | 2018 | 31 | 0.040 |
Why?
| Diagnostic Errors | 1 | 2019 | 162 | 0.040 |
Why?
| RNA Transport | 1 | 2017 | 22 | 0.040 |
Why?
| Hyperplasia | 1 | 2018 | 170 | 0.040 |
Why?
| Loeys-Dietz Syndrome | 1 | 2017 | 6 | 0.040 |
Why?
| GTP-Binding Proteins | 1 | 2018 | 147 | 0.040 |
Why?
| Interleukin-10 | 1 | 1999 | 306 | 0.040 |
Why?
| Skin Irritancy Tests | 1 | 2017 | 3 | 0.040 |
Why?
| Ehlers-Danlos Syndrome | 1 | 2017 | 14 | 0.040 |
Why?
| Anthropometry | 1 | 2018 | 194 | 0.040 |
Why?
| Anti-Bacterial Agents | 2 | 2009 | 1517 | 0.040 |
Why?
| Contraindications, Drug | 1 | 2017 | 7 | 0.040 |
Why?
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 87 | 0.040 |
Why?
| Hirschsprung Disease | 1 | 1999 | 89 | 0.040 |
Why?
| Receptors, CCR2 | 1 | 2017 | 30 | 0.040 |
Why?
| Colorado | 2 | 2017 | 4196 | 0.040 |
Why?
| Pennsylvania | 1 | 2017 | 101 | 0.040 |
Why?
| Observer Variation | 1 | 2018 | 309 | 0.040 |
Why?
| Societies, Scientific | 1 | 2017 | 49 | 0.040 |
Why?
| Attitude to Health | 1 | 2020 | 410 | 0.040 |
Why?
| Nutritional Sciences | 1 | 2017 | 36 | 0.040 |
Why?
| Antibody Specificity | 1 | 2017 | 184 | 0.040 |
Why?
| Endothelium, Vascular | 1 | 2003 | 907 | 0.040 |
Why?
| Pentoxifylline | 1 | 1996 | 22 | 0.040 |
Why?
| Dendritic Cells | 1 | 2020 | 442 | 0.040 |
Why?
| Gene Knockdown Techniques | 1 | 2017 | 311 | 0.040 |
Why?
| Egg Hypersensitivity | 1 | 2017 | 42 | 0.040 |
Why?
| Autophagy-Related Protein 7 | 1 | 2016 | 10 | 0.030 |
Why?
| Societies, Medical | 1 | 2020 | 703 | 0.030 |
Why?
| Hematopoiesis | 1 | 2017 | 175 | 0.030 |
Why?
| Cooperative Behavior | 1 | 2018 | 408 | 0.030 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2018 | 508 | 0.030 |
Why?
| Cross Reactions | 1 | 2015 | 116 | 0.030 |
Why?
| Skin Diseases | 2 | 2012 | 125 | 0.030 |
Why?
| Chloroquine | 1 | 2016 | 64 | 0.030 |
Why?
| Trans-Activators | 1 | 2018 | 373 | 0.030 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 1390 | 0.030 |
Why?
| Polymerase Chain Reaction | 1 | 1998 | 1012 | 0.030 |
Why?
| Psychiatric Status Rating Scales | 1 | 2017 | 499 | 0.030 |
Why?
| Patient Acuity | 1 | 2015 | 37 | 0.030 |
Why?
| Mouth | 1 | 2015 | 74 | 0.030 |
Why?
| In Situ Nick-End Labeling | 1 | 2015 | 124 | 0.030 |
Why?
| Risk Reduction Behavior | 1 | 2017 | 199 | 0.030 |
Why?
| Diagnostic Self Evaluation | 1 | 2015 | 25 | 0.030 |
Why?
| Image-Guided Biopsy | 1 | 2015 | 34 | 0.030 |
Why?
| Area Under Curve | 1 | 2015 | 296 | 0.030 |
Why?
| Lipopolysaccharides | 2 | 2002 | 870 | 0.030 |
Why?
| Chromatin Immunoprecipitation | 1 | 2015 | 135 | 0.030 |
Why?
| Child Health Services | 1 | 2017 | 177 | 0.030 |
Why?
| Antibodies | 1 | 2017 | 392 | 0.030 |
Why?
| Down-Regulation | 1 | 2017 | 627 | 0.030 |
Why?
| Interleukin-1beta | 1 | 2017 | 379 | 0.030 |
Why?
| Mice, Inbred BALB C | 1 | 1997 | 1206 | 0.030 |
Why?
| Electronic Health Records | 1 | 2021 | 830 | 0.030 |
Why?
| Machine Learning | 1 | 2018 | 331 | 0.030 |
Why?
| Bacteria | 1 | 2021 | 757 | 0.030 |
Why?
| Keratinocytes | 1 | 2016 | 227 | 0.030 |
Why?
| Energy Metabolism | 1 | 2020 | 767 | 0.030 |
Why?
| Microscopy, Electron, Transmission | 1 | 2014 | 140 | 0.030 |
Why?
| Proteins | 1 | 2000 | 938 | 0.030 |
Why?
| Lymphocyte Activation | 1 | 1998 | 1067 | 0.030 |
Why?
| T-Lymphocytes | 1 | 2002 | 1774 | 0.030 |
Why?
| Comorbidity | 1 | 2019 | 1527 | 0.030 |
Why?
| Fluorescent Antibody Technique | 1 | 2015 | 410 | 0.030 |
Why?
| Mutagenesis, Site-Directed | 1 | 2015 | 364 | 0.030 |
Why?
| ROC Curve | 1 | 2015 | 473 | 0.030 |
Why?
| Statistics as Topic | 1 | 2015 | 307 | 0.030 |
Why?
| Ileal Diseases | 1 | 1993 | 9 | 0.030 |
Why?
| Leukocytes | 1 | 1995 | 290 | 0.030 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2021 | 2062 | 0.030 |
Why?
| Appetite | 1 | 2013 | 57 | 0.030 |
Why?
| Leukocytes, Mononuclear | 1 | 1996 | 509 | 0.030 |
Why?
| Neisseria meningitidis | 1 | 1993 | 19 | 0.030 |
Why?
| Meningococcal Infections | 1 | 1993 | 20 | 0.030 |
Why?
| Epigenesis, Genetic | 1 | 2017 | 539 | 0.030 |
Why?
| Transcriptional Activation | 1 | 2015 | 349 | 0.030 |
Why?
| Nasal Lavage Fluid | 1 | 2012 | 11 | 0.030 |
Why?
| Macrophages | 1 | 2020 | 1324 | 0.030 |
Why?
| Bacterial Outer Membrane Proteins | 1 | 1993 | 58 | 0.030 |
Why?
| Antigens, Bacterial | 1 | 1993 | 116 | 0.030 |
Why?
| Transcription, Genetic | 3 | 2008 | 1323 | 0.030 |
Why?
| Protein Binding | 1 | 2018 | 1975 | 0.030 |
Why?
| Sinusitis | 2 | 2012 | 175 | 0.030 |
Why?
| Carboxylic Ester Hydrolases | 1 | 2012 | 18 | 0.030 |
Why?
| Prednisone | 1 | 2013 | 235 | 0.030 |
Why?
| Blotting, Western | 1 | 2015 | 1195 | 0.030 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 452 | 0.030 |
Why?
| Immunosuppressive Agents | 1 | 1996 | 683 | 0.030 |
Why?
| Vimentin | 1 | 2012 | 62 | 0.030 |
Why?
| Drug Administration Schedule | 1 | 2014 | 736 | 0.030 |
Why?
| Pneumonia | 1 | 2017 | 592 | 0.030 |
Why?
| Netrin-1 | 1 | 2011 | 11 | 0.030 |
Why?
| Linear Models | 1 | 2014 | 827 | 0.030 |
Why?
| Analysis of Variance | 1 | 2015 | 1295 | 0.030 |
Why?
| Transcriptome | 1 | 2017 | 756 | 0.030 |
Why?
| Keratins | 1 | 2012 | 174 | 0.030 |
Why?
| Transendothelial and Transepithelial Migration | 1 | 2011 | 27 | 0.030 |
Why?
| Heartburn | 1 | 2011 | 11 | 0.020 |
Why?
| Aged, 80 and over | 2 | 2015 | 6562 | 0.020 |
Why?
| Consensus Development Conferences as Topic | 1 | 2011 | 32 | 0.020 |
Why?
| Food Labeling | 1 | 2011 | 16 | 0.020 |
Why?
| Respiratory Tract Diseases | 1 | 2012 | 143 | 0.020 |
Why?
| Cell Differentiation | 1 | 1998 | 1753 | 0.020 |
Why?
| DNA Primers | 2 | 2003 | 533 | 0.020 |
Why?
| Rhinitis | 1 | 2012 | 129 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2015 | 1158 | 0.020 |
Why?
| Computational Biology | 1 | 2014 | 588 | 0.020 |
Why?
| Sputum | 1 | 2012 | 291 | 0.020 |
Why?
| Disease-Free Survival | 1 | 2012 | 649 | 0.020 |
Why?
| Caseins | 1 | 2010 | 22 | 0.020 |
Why?
| Diet, Protein-Restricted | 1 | 2010 | 10 | 0.020 |
Why?
| Radiography, Abdominal | 1 | 2010 | 32 | 0.020 |
Why?
| Colistin | 1 | 2009 | 10 | 0.020 |
Why?
| Emergencies | 1 | 2011 | 153 | 0.020 |
Why?
| Diet, Gluten-Free | 1 | 2010 | 29 | 0.020 |
Why?
| Early Diagnosis | 1 | 2011 | 230 | 0.020 |
Why?
| Mice, Mutant Strains | 1 | 2010 | 280 | 0.020 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 2012 | 613 | 0.020 |
Why?
| Rats | 1 | 1998 | 5394 | 0.020 |
Why?
| Oxidative Stress | 1 | 2016 | 1179 | 0.020 |
Why?
| Mitochondrial Diseases | 1 | 2010 | 79 | 0.020 |
Why?
| Administration, Inhalation | 1 | 2011 | 656 | 0.020 |
Why?
| Guidelines as Topic | 1 | 2011 | 262 | 0.020 |
Why?
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2008 | 21 | 0.020 |
Why?
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2008 | 12 | 0.020 |
Why?
| Staining and Labeling | 1 | 2009 | 146 | 0.020 |
Why?
| Vancomycin | 1 | 2009 | 79 | 0.020 |
Why?
| Adolescent Behavior | 1 | 2013 | 482 | 0.020 |
Why?
| Child Behavior Disorders | 1 | 2010 | 129 | 0.020 |
Why?
| Databases, Genetic | 1 | 2010 | 253 | 0.020 |
Why?
| Sleep | 1 | 2013 | 660 | 0.020 |
Why?
| Physical Examination | 1 | 2010 | 243 | 0.020 |
Why?
| Immunologic Memory | 1 | 2010 | 313 | 0.020 |
Why?
| Bone Morphogenetic Proteins | 1 | 2008 | 137 | 0.020 |
Why?
| Risk Assessment | 1 | 2017 | 3057 | 0.020 |
Why?
| Nasal Polyps | 1 | 1987 | 49 | 0.020 |
Why?
| Health Education | 1 | 2010 | 318 | 0.020 |
Why?
| Weight Loss | 1 | 2011 | 658 | 0.020 |
Why?
| Zebrafish | 1 | 2009 | 437 | 0.020 |
Why?
| Patient Care Team | 1 | 2010 | 522 | 0.020 |
Why?
| Health Personnel | 1 | 2010 | 588 | 0.010 |
Why?
| Genes, Reporter | 1 | 2004 | 270 | 0.010 |
Why?
| Apyrase | 1 | 2003 | 13 | 0.010 |
Why?
| Recombination, Genetic | 1 | 2004 | 173 | 0.010 |
Why?
| Cell Membrane Permeability | 1 | 2003 | 88 | 0.010 |
Why?
| Hydrolysis | 1 | 2003 | 176 | 0.010 |
Why?
| Gene Deletion | 1 | 2004 | 361 | 0.010 |
Why?
| Microcirculation | 1 | 2003 | 155 | 0.010 |
Why?
| Adenosine Triphosphatases | 1 | 2003 | 158 | 0.010 |
Why?
| Passive Cutaneous Anaphylaxis | 1 | 2002 | 5 | 0.010 |
Why?
| Antimicrobial Cationic Peptides | 1 | 2002 | 78 | 0.010 |
Why?
| Cell Line, Tumor | 1 | 2008 | 2851 | 0.010 |
Why?
| Cell Proliferation | 1 | 2008 | 2275 | 0.010 |
Why?
| Antigens, CD | 1 | 2003 | 460 | 0.010 |
Why?
| Oxygen Consumption | 1 | 2003 | 586 | 0.010 |
Why?
| Cardiovascular Diseases | 1 | 2012 | 1802 | 0.010 |
Why?
| Protein Transport | 1 | 2002 | 412 | 0.010 |
Why?
| Salmonella typhimurium | 1 | 2002 | 174 | 0.010 |
Why?
| Carrier Proteins | 1 | 2004 | 726 | 0.010 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2000 | 139 | 0.010 |
Why?
| Antigens, CD1d | 1 | 1999 | 63 | 0.010 |
Why?
| Kinetics | 1 | 2003 | 1625 | 0.010 |
Why?
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 1999 | 7 | 0.010 |
Why?
| Ear | 1 | 1999 | 33 | 0.010 |
Why?
| Swine | 1 | 2002 | 731 | 0.010 |
Why?
| Barium Sulfate | 1 | 1999 | 16 | 0.010 |
Why?
| Capillary Permeability | 1 | 1999 | 140 | 0.010 |
Why?
| Cytoplasm | 1 | 1999 | 269 | 0.010 |
Why?
| Cross-Linking Reagents | 1 | 1999 | 186 | 0.010 |
Why?
| Tyrosine | 1 | 1999 | 233 | 0.010 |
Why?
| Enema | 1 | 1999 | 39 | 0.010 |
Why?
| Cell Membrane | 1 | 2002 | 710 | 0.010 |
Why?
| Milk | 1 | 1999 | 125 | 0.010 |
Why?
| Rectum | 1 | 1999 | 157 | 0.010 |
Why?
| Vasodilator Agents | 1 | 1999 | 328 | 0.010 |
Why?
| Serotonin Antagonists | 1 | 1996 | 31 | 0.010 |
Why?
| Receptors, IgE | 1 | 1996 | 40 | 0.010 |
Why?
| Hypersensitivity, Delayed | 1 | 1996 | 52 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 2000 | 2073 | 0.010 |
Why?
| Contrast Media | 1 | 1999 | 373 | 0.010 |
Why?
| Cell Count | 1 | 1996 | 315 | 0.010 |
Why?
| Apoptosis | 1 | 2004 | 2484 | 0.010 |
Why?
| Drug Synergism | 1 | 1995 | 339 | 0.010 |
Why?
| Cefuroxime | 1 | 1993 | 2 | 0.010 |
Why?
| Serotyping | 1 | 1993 | 32 | 0.010 |
Why?
| Eye Infections, Bacterial | 1 | 1993 | 26 | 0.010 |
Why?
| Cellulitis | 1 | 1993 | 47 | 0.010 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 332 | 0.010 |
Why?
| Immunoblotting | 1 | 1993 | 307 | 0.010 |
Why?
| Immunophenotyping | 1 | 1993 | 278 | 0.010 |
Why?
| Bacteremia | 1 | 1993 | 161 | 0.010 |
Why?
| Skin | 1 | 1995 | 657 | 0.010 |
Why?
| Airway Obstruction | 1 | 1987 | 168 | 0.000 |
Why?
| Neoplasm Recurrence, Local | 1 | 1987 | 900 | 0.000 |
Why?
|
|
Furuta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|